188 related articles for article (PubMed ID: 27072512)
1. Vimentin, colon cancer progression and resistance to butyrate and other HDACis.
Lazarova DL; Bordonaro M
J Cell Mol Med; 2016 Jun; 20(6):989-93. PubMed ID: 27072512
[TBL] [Abstract][Full Text] [Related]
2. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
Bordonaro M; Lazarova DL
World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
[TBL] [Abstract][Full Text] [Related]
3. A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells.
Bordonaro M; Tewari S; Cicco CE; Atamna W; Lazarova DL
PLoS One; 2011; 6(11):e27308. PubMed ID: 22073312
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells.
Lazarova D; Lee A; Wong T; Marian B; Chiaro C; Rainey C; Bordonaro M
J Cancer; 2014; 5(3):203-13. PubMed ID: 24563675
[TBL] [Abstract][Full Text] [Related]
5. ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
Lazarova D; Bordonaro M
J Cancer; 2017; 8(8):1453-1459. PubMed ID: 28638460
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic and Receptor-Mediated Wnt Signaling Influence the Sensitivity of Colonic Cells to Butyrate.
Bordonaro M
J Cancer; 2023; 14(3):446-453. PubMed ID: 36860917
[TBL] [Abstract][Full Text] [Related]
7. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.
Shin J; Carr A; Corner GA; Tögel L; Dávalos-Salas M; Tran H; Chueh AC; Al-Obaidi S; Chionh F; Ahmed N; Buchanan DD; Young JP; Malo MS; Hodin RA; Arango D; Sieber OM; Augenlicht LH; Dhillon AS; Weber TK; Mariadason JM
J Biol Chem; 2014 Sep; 289(36):25306-16. PubMed ID: 25037223
[TBL] [Abstract][Full Text] [Related]
8. CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
Lazarova DL; Chiaro C; Wong T; Drago E; Rainey A; O'Malley S; Bordonaro M
J Cancer; 2013; 4(6):481-90. PubMed ID: 23901348
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression.
Jiang GM; Wang HS; Zhang F; Zhang KS; Liu ZC; Fang R; Wang H; Cai SH; Du J
Biochim Biophys Acta; 2013 Mar; 1833(3):663-71. PubMed ID: 23246564
[TBL] [Abstract][Full Text] [Related]
10. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors.
Bordonaro M; Lazarova DL; Sartorelli AC
Exp Cell Res; 2007 May; 313(8):1652-66. PubMed ID: 17359971
[TBL] [Abstract][Full Text] [Related]
11. Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells.
Bordonaro M; Lazarova DL
JMIR Res Protoc; 2016 May; 5(2):e66. PubMed ID: 27177606
[TBL] [Abstract][Full Text] [Related]
12. p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.
Lazarova DL; Wong T; Chiaro C; Drago E; Bordonaro M
J Cancer; 2013; 4(6):491-501. PubMed ID: 23901349
[TBL] [Abstract][Full Text] [Related]
13. Sodium Butyrate Enhances the Cytotoxic Effect of Etoposide in HDACi-Sensitive and HDACi-Resistant Transformed Cells.
Gnedina OO; Morshneva AV; Igotti MV
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958894
[TBL] [Abstract][Full Text] [Related]
14. [Fiber, cancer stem cells, and the Wnt signaling continuum: possibilities for colorectal cancer prevention and therapeutics].
Bordonaro M; Sartorelli AC
Ai Zheng; 2008 Jul; 27(7):766-70. PubMed ID: 18606074
[TBL] [Abstract][Full Text] [Related]
15. Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
Chiaro C; Lazarova DL; Bordonaro M
Biochem Biophys Res Commun; 2012 Nov; 428(1):121-6. PubMed ID: 23063976
[TBL] [Abstract][Full Text] [Related]
16. Further analysis of p300 in mediating effects of Butyrate in Colorectal Cancer Cells.
Bordonaro M
J Cancer; 2020; 11(20):5861-5866. PubMed ID: 32922528
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors regulate P-gp expression in colorectal cancer via transcriptional activation and mRNA stabilization.
Wang H; Huang C; Zhao L; Zhang H; Yang JM; Luo P; Zhan BX; Pan Q; Li J; Wang BL
Oncotarget; 2016 Aug; 7(31):49848-49858. PubMed ID: 27409663
[TBL] [Abstract][Full Text] [Related]
18. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
[TBL] [Abstract][Full Text] [Related]
19. Hypothesis: Sam68 and Pygo2 mediate cell type-specific effects of the modulation of CBP-Wnt and p300-Wnt activities in Colorectal Cancer Cells.
Bordonaro M
J Cancer; 2021; 12(16):5046-5052. PubMed ID: 34234873
[TBL] [Abstract][Full Text] [Related]
20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
